Category Archives: MS Treatment

For each Teen BurgerTM sold in Canada , $1 will be given to the MS Society MONTREAL , Aug. 20, 2012 /CNW Telbec/ - For a fourth consecutive year, the Multiple Sclerosis Society of Canada invites Quebecers to join the fight against MS as part of its annual fundraising and awareness event, in collaboration with A&W Food Services of Canada Inc. (AW-UN.TO). How can I contribute? Exclusively on Thursday, August 23 , for each Teen Burger sold across the country, one dollar will be donated to help fight MS. The A&W Rendez-vous event will also feature several fundraising activities in participating restaurants, including games, raffles, prizes and even personal appearances by the Great Root Bear himself! Well-known personality Patricia Paquin will be at the Plateau-Mont-Royal A&W restaurant, located at 4501 St-Denis Street, between 11:30 a.m. and 1 p.m. Furthermore, until August 23: "The A&W Rendez-vous to end MS campaign greatly contributes to financing ongoing MS cause and treatment research, as well as services offered to Canadians suffering from this illness, which is diagnosed in three Canadians per day, explains Yves Savoie, President and CEO, MS Society of Canada . We are very grateful toward all donors, as well as A&W … Continue reading →

A Saskatoon man with multiple sclerosis will begin his first day of clinical trials for experimental vein therapy Wednesday in Albany, New York. Andrew Dahlen, 28, is the first of 86 MS patients from Saskatchewan selected to participate in the two-year study. The trial will test the so-called "liberation therapy," in which tiny balloons will be surgically inserted to open constricted veins. All of the the participants will undergo the surgery, but only half will receive the treatment. Wednesday afternoon, Dahlen will be given a drug which will cause him to have temporary amnesia only a local anesthetic is needed for the procedure. The drug is given to make sure Dahlen doesn't remember anything that happens in the operating room. His surgeon will then open an envelope revealing whether Dahlen will receive the liberation therapy or not. "It's been stressful, trying not to show it, but it's stressful," Dahlen told CBC News. But Dahlen said he is okay either way. "I feel like I'm doing something good for Saskatchewan, for research," he said. "I also hope I get the procedure, but if I don't, it will be good research," he said. Dahlen won't officially know if he actually received the … Continue reading →

Multiple sclerosis is a prevalent disease that affects about 250,000 to 350,000 Americans, according to the National Institute of Health. This disease afflicts the brain and spinal cord, which make up the central nervous system, and causes the inflammation of the meninges, a lining of cells that cover the surface of the brain. Though this is, as yet, an incurable disease, MS has many treatment and therapeutic options for patients. A group of Wayne State researchers, along with colleagues in Canada, have found a possible pathway that leads to disease progression which could lead to new therapies for patients. WSU School of Medicine neurology associate chair and professor Joyce A. Benjamins, neurology professor Robert P. Lisak, neurology and immunology & microbiology assistant professor Samia Ragheba, neurology research assistants Liljana Nedelkoskaa and Jennifer Barger all contributed to the study. The main idea behind the study was to see if B cells from patients with MS make substances that could be secreted that could damage CNS cells, Lisak said. B cells are a type of lymphocytes, or white blood cells, that produce antibodies, which help the body in immune responses. In patients with multiple sclerosis, however, the B cells produce molecules that … Continue reading →

Crazy ants create nightmare for Hancock County residents Crazy ants create nightmare for Hancock County residents Updated: Monday, August 20 2012 6:52 AM EDT2012-08-20 10:52:49 GMT Updated: Friday, August 17 2012 12:04 PM EDT2012-08-17 16:04:27 GMT Updated: Tuesday, August 21 2012 6:54 AM EDT2012-08-21 10:54:09 GMT Updated: Friday, August 17 2012 2:44 PM EDT2012-08-17 18:44:29 GMT JACKSON, MS (AP) - Federal court records show a Mississippi company that was the target of the largest U.S. workplace raid on illegal immigrants has settled a discrimination lawsuit by four black women who claimed the company gave preferential treatment to Latinos. A tentative settlement was announced in February. Details were released in court documents filed this past week. U.S. District Court records show Howard Industries will pay $1.3 million into a settlement fund to be paid to possibly as many as 5,000 non-Hispanic individuals who applied for jobs at the company between March 2003 and Aug. 28, 2008. Also, within nine months after the settlement, the company will hire at least 70 of the individuals who had applied for jobs. Immigration agents detained nearly 600 illegal immigrants in the 2008 raid. Read more: Settlement in MS suit over illegal workers … Continue reading →

Heather Sinsels brother Robbie was diagnosed with multiple sclerosis (MS), an autoimmune disease that affects the brain and spinal chord, seven years ago at age 26. Ever since, she and her brother have participated in the MS Challenge Walk, among other MS fundraisers, including a mud run and the MS Walk held annually in Lenape Park in Perkasie. This is the first year hes not walking because hes not well enough, Sinsel said of her brothers health. Since she wont be able to walk with her brother, she decided to make a team of relatives and friends instead and deemed them Robbies Rockstars. So far, participants include Robbies aunt, Patricia DiPippa; his friend, Colleen Penglase; Sinsels friend, Robin Gilles; and, of course, Sinsel herself. Each year Sinsel has participated in the Philadelphia MS Challenge Walk, she has hosted a large fundrasing event. This year, she chose to have a fun morning of Zumba. Ditch the workout, join the party, is Zumbas tagline. The exercise form combines Latin and international music with dance moves that offer an effective full-body workout. Theresa Johnson, who teaches Zumba every Tuesday evening at St. Andrews Church at Dill and Chestnut streets in Perkasie, offered her … Continue reading →

For each Teen BurgerTM sold in Canada , $1 will be given to the MS Society MONTREAL , Aug. 20, 2012 /CNW Telbec/ - For a fourth consecutive year, the Multiple Sclerosis Society of Canada invites Quebecers to join the fight against MS as part of its annual fundraising and awareness event, in collaboration with A&W Food Services of Canada Inc. (AW-UN.TO). How can I contribute? Exclusively on Thursday, August 23 , for each Teen Burger sold across the country, one dollar will be donated to help fight MS. The A&W Rendez-vous event will also feature several fundraising activities in participating restaurants, including games, raffles, prizes and even personal appearances by the Great Root Bear himself! Furthermore, until August 23: "The A&W Rendez-vous to end MS campaign greatly contributes to financing ongoing MS cause and treatment research, as well as services offered to Canadians suffering from this illness, which is diagnosed in three Canadians per day, explains Yves Savoie, President and CEO, MS Society of Canada . We are very grateful toward all donors, as well as A&W guests and employees, for the active role they play year after year to ensure that this important fundraising event is a resounding … Continue reading →

SASKATOON -- A Saskatoon man is going to the U.S. to see if he can take part in a clinical trial of the so-called liberation treatment for multiple sclerosis. Andrew Dahlen is the first Saskatchewan resident to go to Albany, N.Y., for the final eligibility screening in a two-year, double-blind clinical trial. I think the possible benefit will outweigh the real risks of it. Im certainly terrified for going but Im more excited, so Im not really too concerned about the risks, Dahlen said Thursday. The province is putting up $2.2 million to have 86 Saskatchewan patients take part in the trial. All prospective participants are first screened by a neurologist to ensure they meet eligibility requirements. A successful candidate must be a Saskatchewan resident, under the age of 60 and not had liberation treatment. Candidates then spend several days at Albany Medical Centre, where a final assessment determines whether they will be accepted into the trial. The nature of the double-blind study means half of those participating will receive liberation therapy and half will get a placebo procedure. Dahlen, 28, is optimistic. In any scientific test there has to be a control group, so Im thinking even if I … Continue reading →

A Saskatchewan man who is going to the U.S. to see if he can take part in the so-called liberation treatment for multiple sclerosis says hes both terrified and excited. Andrew Dahlen is the first Saskatchewan resident to go to Albany, N.Y., for the final eligibility screening in a two-year, double-blind clinical trial. The province is putting up $2.2 million to have 86 Saskatchewan patients take part. The nature of the double-blind study means half of those participating in the trial will receive liberation therapy and half will get a placebo procedure. Dahlen says even if he were to get the placebo that would still be good research on the progression of MS. The 28-year-old Saskatoon music lover, who lost the ability to play guitar because of the disease, also says the possible benefit would outweigh the risks. The therapy was devised by Italian physician Paolo Zamboni, who has suggested MS may be caused by narrowed veins that prevent blood from properly draining from the brain. He says that could result in iron deposits that damage neurons. Zamboni calls the condition chronic cerebrospinal venous insufficiency, or CCSVI. Zambonis treatment uses balloon angioplasty to open the veins in the same way … Continue reading →

Andrew Dahlen is going to Albany, N.Y. hoping to participate in neck vein clinical trials for his MS. (Steve Pasqualatto/CBC) A Saskatoon man with multiple sclerosis will be the first person sent by the province to the United States to see if he can participate in neck vein therapy clinical trials. Andrew Dahlen will fly to Albany, N.Y., Monday for a final assessment in order to join a two-year study of the so-called liberation therapy for MS. The therapy involves using tiny balloons, surgically inserted, to open up constricted veins. MS is a neurological disease that can seriously affect mobility, vision, speech and bladder function. Hundreds of people from Canada have gone to the U.S. or overseas for the treatment, and many say it has given them relief from their symptoms. However, neck vein therapy is controversial, with a number of medical experts saying it doesn't work, or that the relief it provides is temporary or can be explained by the placebo effect. No Canadian province pays for the procedure, which costs thousands of dollars per treatment, so people who leave the country for it must pay out of their own pockets. Saskatchewan doesn't pay for the procedure either, but … Continue reading →

With a mix of anticipation and fear, Andrew Dahlen will soon learn if he will be Saskatchewans first patient to participate in a clinical trial for a controversial multiple sclerosis treatment. Dahlen who was diagnosed with MS at the age of 22 will travel to Albany, New York on Monday for the final stage of eligibility screening for the clinical trial Chronic Cerebro-Spinal Venous Insufficiency (CCSVI). Its about 70 per cent exciting, 30 per cent terrified. More excited than terrified, said Dahlen, now 28 years old, during a news conference Thursday in Saskatoon. Saskatchewan Health Minister Dustin Duncan called Dahlens trip to New York a groundbreaking day for our province and science, and thanked Dahlen for his willingness to take part in the study. Again, there still are some questions and thats why we want to be a part of trying to find answers to some for those questions, whether this is an effective treatment or not, said Duncan at the news conference. Dahlen will spend several days at the Albany Medical Centre where a final assessment will determine whether he will be accepted into the trial. CCSVI is a controversial MS treatment first hypothesized by Dr. Paolo Zamboni. Zamboni … Continue reading →